Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
AOD 9604 is a synthetic peptide derived from the C-terminus of human growth hormone
The molecule was developed by Frank Ng's group at Monash University and Metabolic Pharmaceuticals in Australia during the 1990s and 2000s as a potential anti-obesity drug intended to isolate the lipolytic region of hGH without activating the growth hormone receptor or raising IGF-1.nnIn published preclinical work, the fragment has been shown to stimulate lipolysis, suppress lipogenesis, and modulate the beta-3 adrenergic receptor pathway in adipose tissue rather than acting through the classical hGH receptor
Clinical: Reduced glycation endproducts (~64% epidermis
Dermicu supports that outcome using a three-part synergy
US$ 23.43
US$ 24.70
US$ 25.88
US$ 21.12
US$ 22.75
US$ 22.40
US$ 22.92
